QRG Capital Management’s Pfizer PFE Stock Holding History

QRG Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.7M	Buy	902,308 +49,804	+6%	+$1.3M	0.18%	103
2026 Q1	$23.9M	Buy	852,504 +146,127	+21%	+$3.89M	0.25%	76
2025 Q4	$17.6M	Buy	706,377 +47,299	+7%	+$1.19M	0.2%	100
2025 Q3	$16.8M	Sell	659,078 -100,825	-13%	-$2.49M	0.2%	100
2025 Q2	$18.4M	Buy	759,903 +59,948	+9%	+$1.4M	0.16%	136
2025 Q1	$17.7M	Buy	699,955 +342,476	+96%	+$8.96M	0.18%	120
2024 Q4	$9.48M	Sell	357,479 -47,576	-12%	-$1.29M	0.1%	193
2024 Q3	$11.7M	Sell	405,055 -60,121	-13%	-$1.75M	0.13%	156
2024 Q2	$13M	Sell	465,176 -51,587	-10%	-$1.42M	0.15%	132
2024 Q1	$14.3M	Sell	516,763 -445,814	-46%	-$12.4M	0.18%	122
2023 Q4	$27.7M	Sell	962,577 -138,607	-13%	-$4.19M	0.41%	52
2023 Q3	$36.5M	Buy	+1,101,184	New	+$38.9M	0.63%	29

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

QRG Capital Management's PFE Position: Q2 2026 in Review

QRG Capital Management increased its Pfizer (PFE) stake by 5.8% in Q2 2026, buying an estimated $1.3M and bringing the position to 902,308 shares worth $21.7M. The position accounts for 0.18% of the portfolio, ranked #103.

QRG Capital Management first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $36.5M in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

QRG Capital Management held 902,308 shares of Pfizer worth $21.7M as of Q2 2026.
QRG Capital Management bought 49,804 Pfizer shares in Q2 2026, an estimated $1.3M.
Pfizer made up 0.18% of QRG Capital Management's portfolio in Q2 2026, its #103 holding.
QRG Capital Management first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
QRG Capital Management's Pfizer position peaked at $36.5M in Q3 2023.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.